Ischemia–reperfusion is a cascade of complex and interrelated pathological processes
underlying many human diseases, including such socially significant diseases as stroke …

The methodology exploring the cardioprotective potential of the flavonoid Fisetin through its
ability to modulate PPAR-γ was unraveled in the present study. Computational modelling …

Background. In the present study, we aimed to find out whether luteolin (Lut) pretreatment
could ameliorate myocardial ischemia/reperfusion (I/R) injury by regulating the lncRNA just …

Coronary artery no‐reflow is a complex problem in the area of reperfusion therapy, and the
molecular mechanisms underlying coronary artery no‐reflow injury have not been fully …

Reperfusion therapy is the most effective treatment for acute myocardial infarction, but it can
damage cardiomyocytes through a mechanism known as myocardial ischemia/reperfusion …

The molecular mechanisms underlying the cardiotoxicity associated with bevacizumab, a
first‐line immunotherapeutic agent used to treat lung cancer, are not fully understood. Here …

Background Acute kidney injury (AKI), the most common complication after cardiac
resuscitation, is highly prevalent and harmful. There is increasing evidence that …

Shenlian (SL) extract has been proven to be effective in the prevention and treatment of
atherosclerosis and myocardial ischemia. However, the function and molecular mechanisms …

Acetylcholine (ACh) has been shown to exert cardioprotection against myocardial
ischemia/reperfusion (I/R) injury. However, whether ACh exerts its cardioprotection …

Objectives Some histone deacetylase (HDAC) isoforms contribute to ischaemia/reperfusion
(IR) injury (IRI). Here, we examined whether LP342, the lead candidate of a new generation …